MedPath

Spironolactone

SPIRONOLACTONE TABLETS, USP 25 mg, 50 mg, 100 mg

Approved
Approval ID

e5bf608e-c6dd-44e8-96aa-ba4660f64de0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 13, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

spironolactone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-960
Application NumberANDA040750
Product Classification
M
Marketing Category
C73584
G
Generic Name
spironolactone
Product Specifications
Route of AdministrationORAL
Effective DateMarch 31, 2010
FDA Product Classification

INGREDIENTS (11)

SPIRONOLACTONEActive
Quantity: 50 mg in 1 1
Code: 27O7W4T232
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
CALCIUM SULFATEInactive
Code: WAT0DDB505
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Spironolactone - FDA Drug Approval Details